Healius (ASX:HLS) Announces Pathology Strategy and $300M Dividend at Investor Day 2025
Healius (ASX:HLS) reveals a new pathology strategy and a $300 million special dividend during Investor Day 2025.
The Hub of Australian Finance News
Healius (ASX:HLS) reveals a new pathology strategy and a $300 million special dividend during Investor Day 2025.
New Zealand King Salmon Investments Ltd (ASX:NZK) reports FY25 results with a net profit of $13.4m and 13% revenue growth.
Teaminvest Private Group Limited (ASX:TIP) extends its share buy-back program for another 12 months, authorising up to 10% of issued capital.
Resolution Minerals (ASX:RML) acquires high-grade antimony and gold projects in NSW and QLD, enhancing its strategic mining portfolio.
Sovereign Metals Limited (ASX:SVM) completes a A$40 million share placement to advance its Kasiya Project in Malawi.
Godolphin Resources (ASX:GRL) raises ~$1.0M through a strategic placement to advance metallurgical and exploration activities at Lewis Ponds project.
BMG Resources (ASX:BMG) accelerates gold exploration at Bullabulling and Invincible Projects, leveraging high-grade discoveries and strategic acquisitions.
Austin Metals Limited (ASX:AYT) raises $1.25M to enhance exploration at key WA gold and copper projects.
Prescient Therapeutics (ASX:PTX) initiates Phase 2a clinical study for PTX-100, marking a significant milestone in treating Cutaneous T-Cell Lymphoma.
AXP Energy Limited (ASX:AXP) announces the scale-up of its second gas-to-power-bitcoin site, aiming for 25 MW/hr generation by CY2025.